Zai Lab Limited
ZLAB
$30.89
$0.431.41%
Weiss Ratings | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.03 | |||
Price History | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -6.90% | |||
30-Day Total Return | 49.08% | |||
60-Day Total Return | 89.98% | |||
90-Day Total Return | 76.31% | |||
Year to Date Total Return | 18.53% | |||
1-Year Total Return | 21.23% | |||
2-Year Total Return | 12.61% | |||
3-Year Total Return | -70.39% | |||
5-Year Total Return | -14.15% | |||
52-Week High % Change | -16.78% | |||
52-Week Low % Change | 125.96% | |||
Price | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $36.60 | |||
52-Week Low Price | $13.48 | |||
52-Week Low Price (Date) | Apr 18, 2024 | |||
52-Week High Price (Date) | Oct 24, 2024 | |||
Valuation | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 2.97B | |||
Enterprise Value | 2.42B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -30.69 | |||
Earnings Per Share Growth | -24.92% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.91 | |||
Price/Book (Q) | 0.42 | |||
Enterprise Value/Revenue (TTM) | 7.57 | |||
Price | $30.89 | |||
Enterprise Value/EBITDA (TTM) | -7.11 | |||
Enterprise Value/EBIT | -6.90 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 9.76M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 86 21 6163 2588 | |||
Address | -- | |||
Website | www.zailaboratory.com | |||
Country | China | |||
Year Founded | 2013 | |||
Profitability | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -109.67% | |||
Profit Margin | -92.44% | |||
Management Effectiveness | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -21.13% | |||
Return on Equity | -- | |||
Income Statement | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 322.71M | |||
Total Revenue (TTM) | 322.71M | |||
Revenue Per Share | $33.07 | |||
Gross Profit (TTM) | 47.27M | |||
EBITDA (TTM) | -343.59M | |||
EBIT (TTM) | -353.92M | |||
Net Income (TTM) | -298.33M | |||
Net Income Avl. to Common (TTM) | -298.33M | |||
Total Revenue Growth (Q YOY) | 45.95% | |||
Earnings Growth (Q YOY) | 33.60% | |||
EPS Diluted (TTM) | -30.69 | |||
EPS Diluted Growth (Q YOY) | 34.35% | |||
Balance Sheet | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 630.05M | |||
Cash Per Share (Q) | $64.56 | |||
Total Current Assets (Q) | 869.92M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 704.18M | |||
Current Ratio (Q) | 3.456 | |||
Book Value Per Share (Q) | $71.75 | |||
Total Assets (Q) | 987.37M | |||
Total Current Liabilities (Q) | 251.72M | |||
Total Debt (Q) | 83.68M | |||
Total Liabilities (Q) | 283.19M | |||
Total Common Equity (Q) | 704.18M | |||
Cash Flow | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 2.92M | |||
Cash from Financing (TTM) | 68.82M | |||
Net Change in Cash (TTM) | -129.78M | |||
Levered Free Cash Flow (TTM) | -393.73M | |||
Cash from Operations (TTM) | -202.47M | |||